Drug Formulation Expert for Intellectual Property Valuation
A drug formulation expert was requested for an economic damages case alleging misappropriation of trade secrets by making a pharmaceutical company's proprietary information available on the internet. The FDA ruled that all pharmaceutical manufacturers must file a New Drug Application for an existing drug in order to control the consistency of the drug formulation and ensure its safety and efficacy. The FDA subsequently made the plaintiff's NDA available on its website, providing easy access for competitors to plaintiff's trade secret formulation.
IMS ExpertServices was asked to provide drug formulation experts with experience in the proprietary aspects of pharmaceuticals, specifically drug formulations and their pharmacology. The expert was needed to consult on the intellectual property valuation of drug formulations in the pharmaceutical industry.
This drug formulation expert is an active consultant in drug discovery and evaluation, medicinal chemistry, and in bioscience licensing agreements and patents. His early work was in pharmaceutical research for Smith Kline where he worked on an earlier formulation of the plaintiff's pharmaceutical product. He is also a registered pharmacist and patent agent. He received his B.S. in pharmacy from the University of California San Francisco and his Ph.D. in medicinal chemistry from the University of California Berkeley. He has extensive experience in litigation support including providing expert witness testimony in both deposition and trial. IMS Reference #1213204
Pharmaceutical Industry Expert
Involved in the pharmaceutical industry for over 30 years, this drug formulation expert offers expertise in many aspects of the pharmaceutical industry. He holds numerous US patents related to the pharmaceutical industry. He is a recognized member of the American Association of Pharmaceutical Scientists and a speaker for AAPS Regional and National meetings. This expert has a bachelor's and a master's degree in chemistry and a Ph.D. in organic chemistry. He is a frequent industry consultant who has previous experience with intellectual property valuation. IMS Reference #332568